Home MRA Applauds Latest Melanoma Drug Approval
 

Keywords :   


MRA Applauds Latest Melanoma Drug Approval

2014-12-29 01:14:14| drugdiscoveryonline Home Page

The Melanoma Research Alliance (MRA) recently welcomed news that the U.S. Food & Drug Administration (FDA) has granted approval to Bristol Myers-Squibb’s new immunotherapy drug, Opdivo (nivolumab), for the treatment of metastatic melanoma

Tags: latest drug approval melanoma

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
02.06Atlantic Tropical Weather Outlook
02.06Eastern North Pacific Tropical Weather Outlook
02.06Eastern North Pacific Tropical Weather Outlook
02.06Atlantic Tropical Weather Outlook
01.06Mining for Pearlizing Agent 
01.06The Power of Zinc Pyrithione
01.06Downward pH Drift
01.06Adding Fragrances to Hot Pours
More »